Douglas Sawyer
Faculty Member
Last active: 7/21/2014

  1. Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes. Pentassuglia L, Graf M, Lane H, Kuramochi Y, Cote G, Timolati F, Sawyer DB, Zuppinger C, Suter TM (2009) Exp Cell Res 315(7): 1302-12
    › Primary publication · 19331811 (PubMed) · PMC4991362 (PubMed Central)
  2. Glutathione peroxidase deficiency exacerbates ischemia-reperfusion injury in male but not female myocardium: insights into antioxidant compensatory mechanisms. Lim CC, Bryan NS, Jain M, Garcia-Saura MF, Fernandez BO, Sawyer DB, Handy DE, Loscalzo J, Feelisch M, Liao R (2009) Am J Physiol Heart Circ Physiol 297(6): H2144-53
    › Primary publication · 19801492 (PubMed) · PMC2793140 (PubMed Central)
  3. Predicting and preventing the cardiotoxicity of cancer therapy. Anderson B, Sawyer DB (2008) Expert Rev Cardiovasc Ther 6(7): 1023-33
    › Primary publication · 18666852 (PubMed)
  4. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Biolo A, Ramamurthy S, Connors LH, O'Hara CJ, Meier-Ewert HK, Soo Hoo PT, Sawyer DB, Seldin DC, Seldin DS, Sam F (2008) Circ Heart Fail 1(4): 249-57
    › Primary publication · 19808299 (PubMed) · PMC2774449 (PubMed Central)
  5. Anthracycline cardiotoxicity: from bench to bedside. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB (2008) J Clin Oncol 26(22): 3777-84
    › Primary publication · 18669466 (PubMed) · PMC3018290 (PubMed Central)
  6. Simultaneous orientation and cellular force measurements in adult cardiac myocytes using three-dimensional polymeric microstructures. Zhao Y, Lim CC, Sawyer DB, Liao R, Zhang X (2007) Cell Motil Cytoskeleton 64(9): 718-25
    › Primary publication · 17615571 (PubMed)
  7. Molecular and cellular mechanisms of anthracycline cardiotoxicity. Chen B, Peng X, Pentassuglia L, Lim CC, Sawyer DB (2007) Cardiovasc Toxicol 7(2): 114-21
    › Primary publication · 17652815 (PubMed)
  8. Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community. Wang TJ, Larson MG, Benjamin EJ, Siwik DA, Safa R, Guo CY, Corey D, Sundstrom J, Sawyer DB, Colucci WS, Vasan RS (2007) Am Heart J 154(2): 291-7
    › Primary publication · 17643579 (PubMed) · PMC3170820 (PubMed Central)
  9. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K (2006) Hypertension 47(5): 887-93
    › Primary publication · 16567591 (PubMed) · PMC3132898 (PubMed Central)
  10. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. Kotlyar E, Vita JA, Winter MR, Awtry EH, Siwik DA, Keaney JF, Sawyer DB, Cupples LA, Colucci WS, Sam F (2006) J Card Fail 12(2): 122-7
    › Primary publication · 16520260 (PubMed)